Pharmacy Benefit Managers Are Not The Cause Of High Prescription Drug Prices

The discounts that PBMs obtain on behalf of insurance companies result in lower health care costs. Abolishing the rebates they obtain for health insurers would result in either a less efficient wholesale pricing structure or higher prices altogether. No one would benefit from such an outcome.

https://www.forbes.com/sites/ikebrannon/2018/06/06/pharmacy-benefit-managers-are-not-the-cause-of-high-prescription-drug-prices/

Read More

Antibody blocks inflammation, protects mice from hardened arteries and liver disease

Researchers at University of California San Diego School of Medicine discovered that they can block inflammation in mice with a naturally occurring antibody that binds oxidized phospholipids (OxPL), molecules on cell surfaces that get modified by inflammation. Even while on a high-fat diet, the antibody protected the mice from arterial plaque formation, hardening of the arteries and liver disease, and prolonged their lives.

https://medicalxpress.com/news/2018-06-antibody-blocks-inflammation-mice-hardened.html

Read More